Clinical Recovery & Injury Repair Assessment
Standard reference ranges describe the average, not your individual baseline. Our practitioners look at 40+ biomarkers to engineer a personalised recovery protocol, which may include peptide therapy where clinically appropriate.
- Understand your personal “recovery ceiling” across 40+ biomarkers
- Newly available treatment focused on cellular repair
- Prescriptions compounded by Australian pharmacies
- No mark-up on medications or hidden service fees
Takes about 5 minutes. Includes an eligibility review and bulk-billed pathology where Medicare criteria are met.*
Most peptides sold online are unregulated
The TGA advises Australians to only obtain prescription medicines through licensed pharmacies under practitioner supervision. Unregulated peptides can pose serious health risks to consumers:
- ~30% mislabelled, under/over-dosed or contaminated
- No guaranteed sterility, with unverified supply chains
- Variable purity and composition the TGA warns could lead to serious harm
- Often contain unsafe concentrations of heavy metals like arsenic or lead
- Can contain harmful bacteria such as haemolytic Bacillus cereus
Sources: TGA safety alert; Sports Medicine (2026); Janvier et al., Talanta (2018); Janvier et al., Drug Testing & Analysis (2018).
Regeniq partners with TGA-licensed Australian compounding pharmacies, when they compound peptides one is sent to the patient and a second is sent to an independent lab for purity testing.
When injecting unregulated peptides, there is no continuity of care or any escalation pathways if you experience unwanted side effects:
- No one is responsible if something goes wrong
- Can be seized at the border, with fines or legal action
- Zero quality control
- Sold as "research use only" to limit liability
Each treatment pathway at Regeniq sits within the Australian regulatory framework, from AHPRA-registered practitioners to licensed compounding pharmacies. No shortcuts, no grey areas.
The regeniq difference
Clinical assessment & suitability overseen by AHPRA-registered Australian practitioners at every step
Medications compounded by TGA-licensed Australian pharmacies
Ongoing care, not a one-off script
Regeniq treatment is guided end to end by registered Australian practitioners. Where clinically appropriate, treatment is prescribed and compounded through TGA-licensed Australian pharmacies, with ongoing review built in.
What’s included
Every protocol is delivered by AHPRA-registered practitioners via secure telehealth consultations.
Recovery and Inflammatory Marker Assessment
Targeted pathology covering hormonal, inflammatory, and metabolic markers tied to muscle recovery, tissue repair, and physical output. Your practitioner reads these results next to your training load and injury history. The goal is to find the clinical reason your body stopped cooperating.
Body Composition Analysis
Body composition changes that don’t match your effort usually have a measurable cause. Your practitioner assesses the clinical factors behind why your body isn’t responding to training and nutrition the way it used to. Blood work, not guesswork.
Musculoskeletal Health Monitoring
Recurring injuries and slow healing often share underlying drivers that never get tested. We identify those factors, monitor them over time through structured follow-up intervals, and adjust your plan based on clinical evidence. Your care evolves as your markers change.
Dealing with slow recovery or recurring injuries?
If your body isn’t responding to training the way it used to, consider joining the waitlist to discuss whether this protocol is appropriate for you.
Frequently asked questions
Who is the performance protocol designed for?
What blood work is included in the recovery assessment?
How is progress tracked over time?
Treatment plans are personalised and prescribed only after medical consultation. Not all patients are suitable candidates. Risks and benefits will be discussed during your consultation. Medicare and private health insurance do not cover these services. Individual results may vary.
*Bulk-billing applies to pathology items that meet Medicare eligibility criteria and are clinically indicated by your practitioner. Some markers may not be Medicare-rebatable.